KFDA approves additional indication of Ultracet

The Korea Food and Drug Administration said that it approved another indication of Janssen Korea's Ultracet for the relief of moderate to severe pain in addition to the short-term management of acute pain.

Thus Ultracet can be applied to patients with chronic pain for the relief of many kinds of pain and it is foreseen that this may contribute to better patients' quality of life in patients....